To the Editor: Patocs et al. (Dec. 20, 2007, issue)1 reporta frequency of TP53 mutations in fibroblasts associated withsporadic breast carcinoma of 27.4%, and they show that mutationstatus is associated with regional nodal metastasis. If confirmed,this finding would represent an important discovery.
We sought to confirm their findings by direct sequencing ofexons 4 through 9 of TP53 in microdissected areas of stroma(<5 mm from the epithelial cancer interface) from 10 fresh-frozensporadic breast-cancer specimens and 7 primary breast-carcinoma–associatedfibroblast cultures.2,3 No mutation was detected in any of these17 samples. The reason for this . . . [Full Text of this Article]
This article has been cited by other articles:
Campbell, I., Polyak, K., Haviv, I., Eng, C., Leone, G., Orloff, M. S., Ostrowski, M. C.
(2009). Clonal Mutations in the Cancer-Associated Fibroblasts: The Case against Genetic Coevolution. Cancer Res.
69: 6765-6769
[Full Text]
Jiang, L., Gonda, T. A., Gamble, M. V., Salas, M., Seshan, V., Tu, S., Twaddell, W. S., Hegyi, P., Lazar, G., Steele, I., Varro, A., Wang, T. C., Tycko, B.
(2008). Global Hypomethylation of Genomic DNA in Cancer-Associated Myofibroblasts. Cancer Res.
68: 9900-9908
[Abstract][Full Text]